Head of Industries, Leasing Advisory; Chair, Global Life Sciences Advisory Board, JLL
Additional details
Artificial intelligence (AI) is proving to be a game-changer in life sciences. AI tools and technologies are revolutionizing data analysis, predicting demand, and transforming drug discovery, design and repurposing. Not only does AI facilitate scientific breakthroughs, it also fosters creativity and collaboration among scientists, propelling innovation to unprecedented heights.
This transformation brings opportunity, but it also leads to unknowns. As discovery and implementation evolves, what does this mean for the physical spaces where therapies are discovered, nurtured and manufactured?
Watch this cutting-edge virtual event to explore how AI might reshape the way life sciences companies think about and take action related to their real estate.
Speakers
Travis McCready
Amber Schiada
Head of Americas Work Dynamics and Industry Research, JLL
Anup Kharode
Partner, Global R&D / Clinical Transformation, PwC